Role of the α7 Nicotinic Acetylcholine Receptor in the Pathophysiology of Atherosclerosis
Open Access
- 23 December 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 11
Abstract
Atherosclerosis constitutes a major risk factor for cardiovascular diseases, the leading cause of morbidity and mortality worldwide. This slowly progressing, chronic inflammatory disorder of large- and medium-sized arteries involves complex recruitment of immune cells, lipid accumulation, and vascular structural remodeling. The α7 nicotinic acetylcholine receptor (α7nAChR) is expressed in several cell types involved in the genesis and progression of atherosclerosis, including macrophages, dendritic cells, T and B cells, vascular endothelial and smooth muscle cells (VSMCs). Recently, the α7nAChR has been described as an essential regulator of inflammation as this receptor mediates the inhibition of cytokine synthesis through the cholinergic anti-inflammatory pathway, a mechanism involved in the attenuation of atherosclerotic disease. Aside from the neuronal cholinergic control of inflammation, the non-neuronal cholinergic system similarly regulates the immune function. Acetylcholine released from T cells acts in an autocrine/paracrine fashion at the α7nAChR of various immune cells to modulate immune function. This mechanism additionally has potential implications in reducing atherosclerotic plaque formation. In contrast, the activation of α7nAChR is linked to the induction of angiogenesis and VSMC proliferation, which may contribute to the progression of atherosclerosis. Therefore, both atheroprotective and pro-atherogenic roles are attributed to the stimulation of α7nAChRs, and their role in the genesis and progression of atheromatous plaque is still under debate. This minireview highlights the current knowledge on the involvement of the α7nAChR in the pathophysiology of atherosclerosis.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (CBB - APQ-02346-17))
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (202401/2018-9).)
This publication has 76 references indexed in Scilit:
- Extramedullary Hematopoiesis Generates Ly-6C high Monocytes That Infiltrate Atherosclerotic LesionsCirculation, 2012
- Evidence for operation of nicotinic and muscarinic acetylcholine receptor-dependent survival pathways in human coronary artery endothelial cellsJournal of Cellular Biochemistry, 2011
- In vivo knockdown of nicotinic acetylcholine receptor α1 diminishes aortic atherosclerosisAtherosclerosis, 2011
- Acetylcholinesterase inhibitors attenuate atherogenesis in apolipoprotein E-knockout miceAtherosclerosis, 2010
- Macrophages from alpha 7 nicotinic acetylcholine receptor knockout mice demonstrate increased cholesterol accumulation and decreased cellular paraoxonase expression: A possible link between the nervous system and atherosclerosis developmentBiochemical and Biophysical Research Communications, 2009
- Cholinergic modulation of angiogenesis: Role of the 7 nicotinic acetylcholine receptorJournal of Cellular Biochemistry, 2009
- Endothelial Nicotinic Acetylcholine Receptors and AngiogenesisTrends in Cardiovascular Medicine, 2008
- Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptorsBiochemical Pharmacology, 2007
- The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammationBritish Journal of Pharmacology, 2007
- Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammationNature, 2002